RFO
AGN

RiverGlades Family Offices’s Allergan plc AGN Stock Holding History

RiverGlades Family Offices’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,980
Closed -$333K – 67
2019
Q3 		$333K Hold
1,980
– – 0.3% 51
2019
Q2 		$332K Sell
1,980
-935
-32% -$129K 0.3% 52
2019
Q1 		$427K Buy
+2,915
New +$423K 0.39% 43
2018
Q4 		– Sell
-2,115
Closed -$403K – 91
2018
Q3 		$403K Sell
2,115
-200
-9% -$36.7K 0.34% 45
2018
Q2 		$386K Sell
2,315
-40
-2% -$6.42K 0.34% 45
2018
Q1 		$396K Buy
2,355
+110
+5% +$18.5K 0.32% 51
2017
Q4 		$367K Buy
+2,245
New +$403K 0.3% 52

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RiverGlades Family Offices's AGN Position: Q4 2019 in Review

RiverGlades Family Offices sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 1,980 shares — an estimated $333K sold.

RiverGlades Family Offices first reported a position in AGN in Q4 2017 and held it in 7 quarters. The position peaked at $427K in Q1 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • RiverGlades Family Offices reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • RiverGlades Family Offices sold 1,980 Allergan plc shares in Q4 2019, an estimated $333K.
  • RiverGlades Family Offices first reported a position in Allergan plc in Q4 2017 and held it in 7 quarters.
  • RiverGlades Family Offices's Allergan plc position peaked at $427K in Q1 2019.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on RiverGlades Family Offices's 13F filing for Q4 2019, filed 18 Feb 2020.